Skip to NavigationSkip to content

News

0
The review will identify areas which may need revision in light of the Rennes clinical trial tragedy
0
Revestive (teduglutide) is indicated for paediatric patients with short bowel syndrome
0
Phase III study met primary endpoint against MabThera/ Rituxan-based treatment

Features

Maintaining that a stringent and complex regulatory process is a must to maintain the quality thresholds, the regulators offer ideas to tackle the...